業績一覧

2025年 業績

論文

英文

  1. Sonoda D, Maruyama R, Kondo Y, Naito M, Mikubo M, Shiomi K, Satoh Y. Predictors and characteristics of late recurrence in non-small cell lung cancer patients 5 years or more after complete resection. Surg Today. 2025 Dec 1. doi: 10.1007/s00595-025-03198-5. Online ahead of print.
  2. Mikubo M, Tamagawa S, Kondo Y, Sonoda D, Naito M, Shiomi K, Ichinoe M, Satoh Y.
    Clinical Significance and Preoperative Prediction of High-Grade Subtypes in Early-Stage Lung Adenocarcinoma Eligible for Sublobar Resection. J Surg Oncol. 2025 Dec;132(8):1407-1415.
  3. Sonoda D, Kondo Y, Maruyama R, Mitsuhashi S, Tamagawa S, Naito M, Mikubo M, Shiomi K, Satoh Y. Characteristics of Patients with Non-Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 20 Q787Q Mutation. Ann Surg Oncol. 2025 Dec;32(13):10170-10178.
  4. Shiomi K, Ichinoe M, Ushiwata A, Nagashio R, Hayashi S, Sonoda D, Kondo Y,
    Tamagawa S, Mitsuhashi S, Sugiyama Y, Naito M, Mikubo M,     Shirasawa M, Nakahara Y, Sato T, Naoki K, Murakumo Y, Eshima K. Insight Into the Significance of CD8+ Tumor-Infiltrating Lymphocytes in Lung Adenocarcinoma. Thorac Cancer. 2025 Jul;16(14):e70135.
  5. Sonoda D, Kondo Y, Tamagawa S, Naito M, Mikubo M, Shiomi K, Yasufuku K, Satoh Y.
    Characteristics of Oligo-Recurrence and Treatment Selection in Non-Small Cell Lung Cancer. Cancers (Basel). 2025 Jul 10;17(14):2293
  6. Minami Y, Takenaka A, Hiroshima K, Yoshizawa A, Haba R, Kawahara K, Shibuki Y, Miyake S,
    Kakinuma H, Satoh Y. New WHO Reporting System for Lung Cytopathology: Reproducibility Test of the Diagnosis and Usefulness of an Online Tutorial System for the New Cytological Categorization. Acta Cytol 28:1-37. 2025.
  7. Matsuo Y, Yoshida T, Yamashita K, Satoh Y. Effect on DNA Stability of a Novel Pellet Storing Method for Liquid-Based Cytology Specimens Fixed Using an Alcohol-Based Preservation Solution: Studies Using EGFR Mutation Detection on a Lung Adenocarcinoma Cell Line. Acta Cytol 11:1-10. 2025.
  8. Sonoda D, Maruyama R, Kondo Y, Naito M, Mikubo M, Shiomi K, Satoh Y. Treatment selection pattern and prognostic factors in older patients with non-small cell lung cancer at recurrence: an observational study. Surgery Today 55(4):588-599, 2025.
  9. Sonoda D, Kondo Y, Maruyama R, Naito M, Mikubo M, Shiomi K, Satoh Y. Prognostic factors after radical local therapy for oligo-recurrence of non-small cell lung cancer. Gen Thorac Cardiovasc Surg. 2025 May;73(5):352-361.
  10. Sonoda D, Kondo Y, Naito M, Mikubo M, Shiomi K, Satoh Y. Clinical course after radical local therapy for oligo-recurrence of non-small cell lung cancer. J Surg Oncol. 2025 Jun;131(8):1551-1561.
  11. Hayashi S, Ichinoe M, Sakurai Y, Kesen Y, Kato T, Sanoyama I, Hoshino A, Shiomi K,
    Mikubo M, Satoh Y, Murakumo Y. Elevated expression of REV7 correlates with poor prognosis in lung adenocarcinoma and its inactivation in carcinoma cells enhances chemosensitivity. Pathol Res Pract 266:155779, 2025.
  12. Kesen Y, Ichinoe M, Hayashi S, Umezawa A, Numata Y, Kogami T, Matsushita M, Sanoyama I,
    Hoshino A, Sakurai Y, Kato T, Murakumo Y. High levels of REV7 expression are associated with poor prognosis and chemoresistance in gastric adenocarcinoma. Pathol Int. 2025 Jan;75(1):21-33.

和文

  1. 吉沢明成,今村駿,江郷隼一郎,馬場香子,佐藤之俊. 手背に生じた筋周皮腫(Myopericytoma)の治療経験. 埼玉県医学会雑誌 59(1):301-305, 2025.

その他

  1. 佐藤之俊. 日本肺癌学会編. 臨床・病理 肺癌取扱い規約 第9版, 金原出版, 東京, 2025.
  2. 佐藤之俊. 石綿・中皮腫研究会,日本中皮腫研究機構,日本肺癌学会編. 中皮腫瘍取扱い規約 第2版, 金原出版, 東京, 2025.
  3. 佐藤之俊,松尾由紀子. 日本臨床細胞学会. がんゲノム診療における細胞検体の取扱い指針 第2版  https://cdn.jscc.or.jp/wp-content/themes/jscc/guidelines/2024/genome_guidelines_2nd%200220.pdf

ページTOPへ戻る